Showing 2121-2130 of 3329 results for "".
- New Product Line for Hair, Scalp Introduced by Elevai Labs Inc.https://modernaesthetics.com/news/new-product-line-for-hair-scalp-introduced-by-elevai-labs-inc/2473616/Elevai Skincare, a subsidiary of Elevai Labs Inc., announced the Elevai S-Series, a hair and scalp product line. The three-part hair and scalp care system combines the power of exosomes with advanced mitochondrial technology. The product incorporates Elevai’s proprietary pre
- Cosmetic Surgeries, Procedures Gaining Popularity Among Gen Zhttps://modernaesthetics.com/news/cosmetic-surgeries-procedures-gaining-popularity-among-gen-z/2473609/A new report reveals the most popular cosmetic surgeries and procedures among Gen Z. The American Society of Plastic Surgeons (ASPS) released its annual report earlier this week. More Americans are turning to plastic surgery and minimally invasive procedures. There was a 5% increa
- Performance Beauty Company Submits Premarket Approval Application for Dermal Filler Productshttps://modernaesthetics.com/news/performance-beauty-company-submits-premarket-approval-application-for-dermal-filler-products/2473607/Evolus, Inc. submitted the final module of its permarket approval (PMA) application to the US Food and Drug Administration for dermal filler products. Evolysse Lift and Evolysse Smooth dermal fillers are for the nasolabial fold (NLF). Evolus expects the FDA’s
- Cutera Academy Starts Stronghttps://modernaesthetics.com/news/cutera-academy-starts-strong/2473606/Cutera, Inc. announced positive initial feedback from its recently launched Cutera Academy, a comprehensive educational program designed to enhance provider expertise and practice success with AviClear®. “At Cutera, we believe in the power of partnerships,” Taylor Harris
- US Aesthetic Medicine Market to Reach $136.69 Billion By 2033https://modernaesthetics.com/news/us-aesthetic-medicine-market-to-reach-13669-billion-by-2033/2473602/The US aesthetic medicine market is expected to grow exponentially over the next 9 years. A new market research report projects the industry will reach $136.69 billion by 2033, expanding at a compound annual growth rate (CAGR) of 13.6%. The industry was calculated at $43.38 billio
- Doctor Issues Warning After TikTok Star’s Dangerous Use of Expired Productshttps://modernaesthetics.com/news/doctor-issues-warning-after-tiktok-stars-dangerous-use-expired-products/2473599/
- Deadline for Cosmetic Product Manufacturers to Comply with New Federal Regulations Quickly Approachinghttps://modernaesthetics.com/news/deadline-for-cosmetic-product-manufacturers-to-comply-with-new-federal-regulations-quickly-approaching/2473598/A new deadline is quickly approaching for cosmetic product manufacturers to comply with federal regulations. Cosmetic products companies are required to register facilities, list products and report serious adverse events by July 1. The companies must also develop and maintai
- Registration Opens for 2024 ASDS Annual Meetinghttps://modernaesthetics.com/news/registration-opens-for-2024-asds-annual-meeting/2473596/The American Society for Dermatologic Surgery opened registration for its 2024 ASDS Annual Meeting in Orlando, Florida from October 17-20. The educational conference is for dermatologic surgeons specializing in cosmetic, reconstruction, and skin cancer procedures. There will be ov
- Exosome Diagnostics and Therapeutics Market Expected to Surgehttps://modernaesthetics.com/news/exosome-diagnostics-and-therapeutics-market-expected-to-surge/2473588/Emerging potential of exosome-based liquid biopsy is a primary factor driving the growth of the market. The Exosome Diagnostics and Therapeutics market is expected to surge from $59 million in 2024 to $6.848 billion by 2032 with a compound annual growth rate of 108.9%. The exosome
- Natural alternative for Salicylic Acid to manage skin, acne care introducedhttps://modernaesthetics.com/news/new-alternative-salicylic-acid-manage-skin-acne-care-introduced/2473586/A more natural way to manage skin and acne care is entering the market. Active Concepts introduced ACB Sal-Vation as an alternative to salicylic acid. It’s made up of benzoic acid, naturally found in prunes, and succinic acid, naturally found in sugar beets.